0001237899-12-000085.txt : 20121121
0001237899-12-000085.hdr.sgml : 20121121
20121121155036
ACCESSION NUMBER: 0001237899-12-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121120
FILED AS OF DATE: 20121121
DATE AS OF CHANGE: 20121121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAHL NEIL
CENTRAL INDEX KEY: 0001226689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 121221215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2012-11-20
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226689
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Res and Devel Sciences
Common Stock
2012-11-20
4
M
0
17000.0
16.8
A
76121.0
D
Common Stock
2012-11-20
4
F
0
1708.0
167.17
D
74413.0
D
Common Stock
2012-11-20
4
F
0
7694.0
167.17
D
66719.0
D
Common Stock
2012-11-20
4
M
0
37500.0
16.8
A
104219.0
D
Common Stock
2012-11-20
4
F
0
3768.0
167.17
D
100451.0
D
Common Stock
2012-11-20
4
F
0
16973.0
167.17
D
83478.0
D
Common Stock
2012-11-21
4
S
0
9200.0
173.8
D
74278.0
D
Common Stock
2012-11-21
4
S
0
13157.0
174.47
D
61121.0
D
Common Stock
2012-11-21
4
S
0
2000.0
175.49
D
59121.0
D
Common Stock
5479.0
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
16.8
2012-11-20
4
M
0
17000.0
D
2018-12-17
Common Stock
17000.0
52048.0
D
Non-Qualified Stock Option (right to buy)
16.8
2012-11-20
4
M
0
37500.0
D
2018-12-17
Common Stock
37500.0
14548.0
D
Represents volume-weighted average price of sales of 9,200 shares of Company stock on November 21, 2012 at prices ranging from $173.17 to $173.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 21, 2012 at each separate price.
Represents volume-weighted average price of sales of 13,157 shares of Company stock on November 21, 2012 at prices ranging from $174.00 to $174.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 21, 2012 at each separate price.
Represents volume-weighted average price of sales of 2,000 shares of Company stock on November 21, 2012 at prices ranging from $175.00 to $175.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 21, 2012 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2011, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2011.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**Neil Stahl
2012-11-21